S.J. Winsper

Aston University, Birmingham, England, United Kingdom

Are you S.J. Winsper?

Claim your profile

Publications (7)1.52 Total impact

  • Sarah J. Winsper · Richard A. Armstrong · Paul S. Hodgkins · John A. Blair ·
    [Show abstract] [Hide abstract]
    ABSTRACT: The binding of gallium (Ga) to transferrin (Tf) was studied in plasma from control patients, in patients with untreated Parkinson's disease (PD) and in patients with PD treated either with levodopa (L-dopa) alone or in combination with selegiline. Mean percentage Ga-Tf binding was significantly reduced in untreated and treated PD compared with controls. Binding, however, was significantly greater in treated than in untreated patients. There was no difference in binding between patients treated with L-dopa alone and those treated with L-dopa and selegiline. The data support the hypothesis that oxidation reactions may be of pathogenic significance in PD.
    Neuroreport 03/1997; 8(3):709-11. DOI:10.1097/00001756-199702100-00026 · 1.52 Impact Factor
  • R.A. Armstrong · S.J. Winsper · J.A. Blair ·
    [Show abstract] [Hide abstract]
    ABSTRACT: Chronic exposure to aluminium (Al) remains a controversial possible cause of sporadic forms of Alzheimer's disease (AD). This article reviews the evidence that once Al enters the brain and individual brain cells, it may be involved in three pathological processes: (1) the production of abnormal forms of tau leading to the formation of cellular neurofibrillary tangles and neuropil threads; (2) the processing of the amyloid precursor protein, resulting in the formation of beta-amyloid deposits and senile plaques, and (3) that via the mutual histocompatibility system, Al could be involved in the initiation of the immune response observed in AD patients. Despite recent evidence that Al could be involved in these processes, a conclusive case that exposure to Al initiates the primary pathological process in sporadic AD remains to be established.
    Dementia (Basel, Switzerland) 01/1996; 7(1):1-9. DOI:10.1159/000106845
  • R.A. Armstrong · S J Winsper · J.A. Blair ·
    [Show abstract] [Hide abstract]
    ABSTRACT: A hypothesis that a metal-induced immune disorder may be involved in the pathogenesis of some forms of Alzheimer's disease (AD) is presented. The classical complement pathway is activated in AD and T cells and reactive microglia appear in the brain. Studies of metal induced autoimmunity and the use of compounds containing aluminium as vaccine adjuvants suggest that metals can activate complement and can be taken up by antigen presenting cells. The consequent immune response could contribute to neuronal damage, beta-amyloid deposition and cell death. The strengths and weaknesses of this hypothesis are discussed and tests of some aspects are proposed.
    Neurodegeneration 04/1995; 4(1):107-11. DOI:10.1006/neur.1995.0013
  • R.A. Armstrong · R .J. Cattell · S.J. Winsper · J.A. Blair ·
    [Show abstract] [Hide abstract]
    ABSTRACT: The levels of neopterin, biopterin and the neopterin/biopterin ratio (N/B) were measured in urine samples taken from normal young and elderly control subjects, exceptionally healthy elderly control subjects classified according to the ‘Senieur’ protocol and patients with Down’s syndrome (DS) or Alzheimer’s disease (AD). The N/B ratio was approximately unity in control groups with the exception of the normal elderly controls. The levels of neopterin and biopterin declined with age in the exceptionally healthy ‘Senieur’ control group. The N/B ratio was elevated in young and old DS patients as a result of the significant increase in neopterin. Neopterin levels were significantly elevated in AD patients compared with the healthy elderly controls, but this did not result in a significant increase in the N/B ratio in these patients. The N/B ratio increased with age in AD patients as a result of a decline in biopterin. These results suggested that there is a cellular immune reponse in DS and AD patients which in DS, may precede the formation of beta-amyloid deposits in the brain. In addition, there may be a deficiency in tetrahydrobiopterin biosynthesis in AD which becomes more marked with age.
    01/1995; 6(4). DOI:10.1515/pteridines.1995.6.4.185
  • [Show abstract] [Hide abstract]
    ABSTRACT: Neopterin, an unconjugated pteridine, is secreted in large quantities by activated macrophages and can be used as a clinical marker of activated cellular immunity in a patient. Hence, neopterin levels were measured in urine samples taken from patients with Down’s syndrome (DS), non-hospitalized and hospitalized Alzheimer’s disease (AD) and age and sex matched controls. All subjects and patients were free from infectious and malignant disease. A significant effect of age on urinary neopterin levels was found in control subjects, levels being greater in younger and older subjects. No significant trends with age were found in AD and DS patients. The mean level of neopterin was significantly increased in DS and AD compared with age matched controls suggesting immune activation in these patients. In DS, elevated neopterin levels were present in individuals at least 17yrs old suggesting that immune activation could be associated with the initial deposition of beta/A4 in the brain.
  • J A Blair · A Williams · H Wachter · D Fuchs · H Pall · Richard A. Armstrong · S.J. Winsper ·

  • Sarah Jane. Winsper ·
    [Show abstract] [Hide abstract]
    ABSTRACT: Thesis (Ph. D.)--University of Aston in Birmingham, 1995.